GARDP

News

EU invests €30m to fight antimicrobial resistance

The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

News

Innoviva’s ‘game changer’ antibiotic tackles gonorrhoea

Innoviva has moved a step closer to bringing the first novel antibiotic to market for gonorrhoea in decades after reporting positive results in a phase 3 trial.

News

Eisai, Takeda and GARDP hunt for new antibiotics

The not-for-profit Global Antibiotic Research and Development Partnership has joined forces with Eisai and Takeda to search for new antibiotics.

EU invests €30m to fight antimicrobial resistance

Innoviva’s ‘game changer’ antibiotic tackles gonorrhoea

Eisai, Takeda and GARDP hunt for new antibiotics

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks